The Latest on Omicron Subvariant BA.2 in the US, 4th Dose of COVID-19 Vaccine, and Vaccination in Children
Program Description The IAS–USA COVID-19 Dialogues bring together leading experts to discuss what the data and research are telling us about the basic science, public health, and clinical aspects of COVID-19 and the consequences of the pandemic. This Dialogue will provide a robust and relevant discussion of COVID-19 and SARS-CoV-2, including the 4th dose of (more…)
Detailed Discussion on the Most Current Issues in COVID-19 Therapeutics, 2nd Booster, Variants of Variants, and COVID-19 in Children
Program Description The IAS–USA COVID-19 Dialogues bring together leading experts to discuss what the data and research are telling us about the basic science, public health, and clinical aspects of COVID-19 and the consequences of the pandemic. Note, Dialogues are intended for healthcare clinicians and researchers. Sign Up Please use the following link to sign (more…)
Detailed Discussion on the Latest Issues in Current and Next Generation COVID-19 Vaccines, Boosters, Therapeutics, New Variants, Continued Surge in Cases, and More
Program Description The IAS–USA COVID-19 Dialogues bring together leading experts to discuss what the data and research are telling us about the basic science, public health, and clinical aspects of COVID-19 and the consequences of the pandemic. This Dialogue will provide a robust and relevant discussion of COVID-19 and SARS-CoV-2, including updates on: Current COVID-19 (more…)
Detailed Discussion on the Latest Issues in COVID-19 Rebound, Omicron Subvariants BA.4 and BA.5, Current and Next Generation COVID-19 Vaccines, Pediatric Vaccine Rollout, Monkeypox, and More
Program Description The IAS–USA COVID-19 Dialogues bring together leading experts to discuss what the data and research are telling us about the basic science, public health, and clinical aspects of COVID-19 and the consequences of the pandemic. This Dialogue will provide a robust and relevant discussion of COVID-19 and SARS-CoV-2 at the time. Note, Dialogues (more…)
Latest Update on Urgent Virus Outbreaks: COVID-19, Monkeypox, and the Resurgence of Vaccine-Preventable Diseases
Program Description The IAS–USA COVID-19 Dialogues bring together leading experts to discuss what the data and research are telling us about the basic science, public health, and clinical aspects of COVID-19 and the consequences of the pandemic. The IAS–USA COVID-19 Dialogues bring together leading experts to discuss what the data and research are telling us (more…)
Continued Discussion on Urgent Virus Outbreaks: COVID-19, Monkeypox, and the Resurgence of Vaccine-Preventable Diseases
Program Description The IAS–USA Dialogues bring together leading experts to discuss what the data and research are telling us about the basic science, public health, and clinical aspects of COVID-19 and the consequences of the pandemic. This Dialogue will provide a robust and relevant discussion of urgent virus outbreaks, particularly COVID-19 and monkeypox at the (more…)
Latest Update on Urgent Virus Outbreaks: COVID-19, Respiratory Syncytial Virus, and Influenza
Program Description The IAS–USA Dialogues bring together leading experts to discuss what the data and research are telling us about the basic science, public health, and clinical aspects of COVID-19 and the consequences of the pandemic. This Dialogue will provide a robust and relevant discussion of urgent virus outbreaks, particularly COVID-19, respiratory syncytial virus (RSV), (more…)
Detailed Discussion on the Latest Issues in COVID-19: Vaccines, Long COVID, Prevention, and Pediatrics
Program Description The IAS–USA Dialogues bring together leading experts to discuss what the data and research are telling us about the basic science, public health, and clinical aspects of COVID-19 and the consequences of the pandemic. This Dialogue will provide a robust and relevant discussion of urgent virus outbreaks at the time. Note, Dialogues (more…)
Latest Update on Urgent Virus Outbreaks: March 2023
Program Description The IAS–USA Dialogues bring together leading experts to discuss what the data and research are telling us about the basic science, public health, and clinical aspects of COVID-19 and the consequences of the pandemic. This Dialogue will provide a robust and relevant discussion of urgent virus outbreaks at the time. Note, Dialogues are (more…)
Latest Update on Urgent Virus Outbreaks: April 2023
Program Description The IAS–USA Dialogues bring together leading experts to discuss what the data and research are telling us about the basic science, public health, and clinical aspects of COVID-19 and the consequences of the pandemic. This Dialogue will provide a robust and relevant discussion of urgent virus outbreaks at the time. Note, Dialogues are (more…)